Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol
- PMID: 8647598
Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol
Abstract
Two different anticoagulation protocols were used in 49 consecutive patients mechanically supported either for bridge to transplantation (11) or for recovery of myocardial function after cardiac surgery (35). In 46 patients a Biomedicus centrifugal pump was used and in 3 patients a Pierce-Donachy ventricles. Mechanical support was provided to the left ventricle in 14 patients, to the right ventricle in 6 and to both ventricles in 12 patients; an extra-corporeal membrane oxygenator (ECMO) support was used in 17 patients. Thirty-seven males and 12 females, aged 0.2 to 58 years, were supported for an average time of 6.3 days (range 1-43). Anticoagulation was either based on a continuous infusion of heparin in the first 27 patients (group A) or on a multi-system therapy ("La Pitié" protocol) in the other 22 patients (group B). Overall survival rate was 47%. Patients in group A had a 30% (8/27) survival rate, whereas in group B a 68% (15/22) survival rate was observed (p = 0.006). Transplantation and ventricular assist device (VAD) removal was successfully obtained in 59% (16/27) and 91% (20/22) of patients in group A and group B respectively (p = 0.05). Significant bleeding occurred in 21 patients (81%) in group A and in 2 (9%) of group B (p = 0.001). In these patients bleeding averaged 230 +/- 231 ml/kg in group A versus 55 +/- 18 ml/kg in group B (p = 0.001). Surgical revision was necessary for cardiac tamponade or persistent bleeding in 12 patients of group A (25 procedures: mean 0.9/patient) and in 3 patients of group B (one each patient: mean 0.1/patient) (p = 0.01). Infection, thrombo-embolism and brain hemorrhage were also less frequent in group A than in group B. Our data suggest that the "La Pitié" protocol provides a better control of bleeding than the conventional heparin infusion in patients receiving assist device. this reduction in thrombo-hemorrhagic complications might improve the results of mechanical circulatory support.
Similar articles
-
Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart.Int J Artif Organs. 1995 Oct;18(10):633-48. Int J Artif Organs. 1995. PMID: 8647597
-
Seven years' experience with the Pierce-Donachy ventricular assist device.J Thorac Cardiovasc Surg. 1988 Dec;96(6):901-11. J Thorac Cardiovasc Surg. 1988. PMID: 3057290
-
A method for anticoagulation of children on mechanical circulatory support.Artif Organs. 2011 Nov;35(11):1018-23. doi: 10.1111/j.1525-1594.2011.01391.x. Artif Organs. 2011. PMID: 22097979
-
Coagulation management in patients undergoing mechanical circulatory support.Best Pract Res Clin Anaesthesiol. 2012 Jun;26(2):179-98. doi: 10.1016/j.bpa.2012.04.003. Best Pract Res Clin Anaesthesiol. 2012. PMID: 22910089 Review.
-
Anticoagulation with VADs and ECMO: walking the tightrope.Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):674-680. doi: 10.1182/asheducation-2017.1.674. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222320 Free PMC article. Review.
Cited by
-
Antithrombotic therapy for the CardioWest temporary total artificial heart.Tex Heart Inst J. 2010;37(2):149-58. Tex Heart Inst J. 2010. PMID: 20401285 Free PMC article. Review.
-
Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children.Pediatr Rep. 2022 Jul 11;14(3):320-332. doi: 10.3390/pediatric14030039. Pediatr Rep. 2022. PMID: 35894028 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical